Medical Artificial Intelligence: Opportunities and Challenges In Infectious Disease Management

Globally, millions of individuals suffer from infectious diseases, which are major public health concerns caused by bacteria, fungi, viruses, or parasites. These diseases can be transmitted directly or indirectly from person to person, potentially leading to a pandemic or epidemic. Several advancements have been made in molecular genetics for infectious disease management, which include pharmaceutical chemistry, medicine, and infection tracking; however, these advancements still lack control over human infections. Multidisciplinary cooperation is needed to address and control human infections. Advancements in scientific tools have empowered scientists to enhance epidemic prediction, gain insights into pathogen specificity, and pinpoint potential targets for drug development. Artificial intelligence (AI)-based methodologies demonstrate significant potential for integrating large-scale quantitative and omics data, enabling effective handling of biological complexity. Machine Learning (ML) plays a crucial role in AI by leveraging data to train predictive models. AI can enhance diagnostic accuracy through objective pattern recognition, standardize infection diagnoses with implications for Infection Prevention and Control (IPC), and aid in generalizing IPC knowledge. Additionally, AIpowered hand hygiene applications have the potential to drive behavioral change, although further evaluation in diverse clinical contexts is necessary. This review article highlights AI's potential in improving the healthcare system in different aspects of infectious diseases management, such as monitoring disease growth, using a real-time chatbot for patient assistance, using image processing for diagnosis, and developing new treatment algorithms. The study also discusses future directions for novel vaccine and drug development, as well as other aspects, such as the need for physicians and healthcare professionals to receive AI system training for their correct use and the ability of doctors to identify and resolve any problems that may arise with AI.

Authors

Institutions

Publication Details

Journal
Current Medicinal Chemistry
Published
2025-08-22
DOI
https://doi.org/10.2174/0109298673390868250728103906
Primary Topic
COVID-19 diagnosis using AI
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Medical Artificial Intelligence: Opportunities and Challenges In Infectious Disease Management

Jonathan A. Lal, Alhussain H. Aodah, Jagdish Singh, Mahfoozur Rahman et al.
Current Medicinal Chemistry
COVID-19 diagnosis using AI
article

Medical Artificial Intelligence: Opportunities and Challenges In Infectious Disease Management

Jonathan A. Lal, Alhussain H. Aodah, Jagdish Singh, Mahfoozur Rahman, Salem Salman Almujri, Ankit Sahoo, Kainat Alam, Nabil K. Alruwaili, Majed Alrobaian, Md. Abul Barkat, Tanuja Singh, Waleed Hassan Almalki
article en

Abstract

Globally, millions of individuals suffer from infectious diseases, which are major public health concerns caused by bacteria, fungi, viruses, or parasites. These diseases can be transmitted directly or indirectly from person to person, potentially leading to a pandemic or epidemic. Several advancements have been made in molecular genetics for infectious disease management, which include pharmaceutical chemistry, medicine, and infection tracking; however, these advancements still lack control over human infections. Multidisciplinary cooperation is needed to address and control human infections. Advancements in scientific tools have empowered scientists to enhance epidemic prediction, gain insights into pathogen specificity, and pinpoint potential targets for drug development. Artificial intelligence (AI)-based methodologies demonstrate significant potential for integrating large-scale quantitative and omics data, enabling effective handling of biological complexity. Machine Learning (ML) plays a crucial role in AI by leveraging data to train predictive models. AI can enhance diagnostic accuracy through objective pattern recognition, standardize infection diagnoses with implications for Infection Prevention and Control (IPC), and aid in generalizing IPC knowledge. Additionally, AIpowered hand hygiene applications have the potential to drive behavioral change, although further evaluation in diverse clinical contexts is necessary. This review article highlights AI's potential in improving the healthcare system in different aspects of infectious diseases management, such as monitoring disease growth, using a real-time chatbot for patient assistance, using image processing for diagnosis, and developing new treatment algorithms. The study also discusses future directions for novel vaccine and drug development, as well as other aspects, such as the need for physicians and healthcare professionals to receive AI system training for their correct use and the ability of doctors to identify and resolve any problems that may arise with AI.

Current Medicinal ChemistryVol. 33(8)
Prince Sattam Bin Abdulaziz University (SA), Taif University (SA), Umm al-Qura University (SA), Jouf University (SA), Sam Higginbottom Institute of Agriculture (IN), KES College (CY), Central University of Tibetan Studies (IN), University of Hafr Al-Batin (SA), Block Center (US), Jamia Millia Islamia (IN), King Khalid University (SA)
Openalex Percentile: Top 69%
COVID-19 diagnosis using AI
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.